As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs.
Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl.
The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across North America.
OBJ360 (Sponsored)
How the uOttawa faculty of engineering instills an ‘entrepreneurial mindset’ in students
A decade ago, Terrafixing chief operating officer Vida Gabriel was a chemistry-loving student in high school with little to no interest in business or entrepreneurship. “I didn’t like the sales
The value of an Algonquin College degree: Experiential learning, taught by industry experts
Zaahra Mehsen was three years into a biology degree at a local university when she realized she wanted to take a different path. “I realized that it’s not my thing,”
“We want this to be in the hands of everybody whose job it is to save lives in this crisis,” says company co-founder and CEO Malcolm Eade.
Learn more about Spectra Plasmonics by watching the full interview with Eade above.
